6314-27-8

Usage

Uses

Used in Pharmaceutical Research:
(8-carboxynaphthalen-1-yl)mercury is used as a research compound for studying its properties and potential applications in the development of pharmaceuticals.
Used in Organic Chemistry:
(8-carboxynaphthalen-1-yl)mercury is used as a reagent in organic synthesis for the preparation of various organic compounds.
Used in Chemical Synthesis:
(8-carboxynaphthalen-1-yl)mercury is used as a chemical intermediate in the synthesis of other complex organic molecules.
It is important to use caution and proper safety measures when working with or handling (8-carboxynaphthalen-1-yl)mercury to minimize the potential risks associated with its use, as it poses significant environmental and health risks, especially if mishandled or improperly disposed of.

Upstream product

• 81-84-5 1,8-Naphthalic anhydride 
• 1600-27-7 mercury(II) diacetate 
• 631-60-7 mercury (I) acetate 
• 24050-49-5 3-bromonaphthalic-1,8-anhydride 
• 12653-71-3 mercury(II) oxide 

Downstream Products

• 86-55-5 1-naphthalenecarboxylic acid 
• 3965-09-1 8-Borono-1-naphthoesaeure 
• 16726-66-2 3-bromo-1-naphthoic acid 
• 1366068-23-6 JWH-417 
• 1366068-19-0 JWH-416 
• 1366068-07-6 JWH-425 
• 1366068-04-3 (8-bromonaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone 
• 1729-99-3 8-bromonaphthalene-1-carboxylic acid 
• 13577-19-0 8-iodo-1-naphthoic acid 
• 86456-61-3 o-<(8-bromo-1-naphthyl)methyl>acetophenone 

Relevant academic research and scientific papers

Synthesis and photophysical properties of a porphyrin-perinaphthothioindigo dye

A new porphyrin-perinaphthothioindigo composite, where porphyrin and perinaphthothioindigo dye are connected though a triple bond, was synthesized. In UV-vis absorption spectra of the composite, absorption originating from the trans-isomer appeared at 655

THIAZOLE DERIVATIVES AS SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention relates to a novel compound with thiazole ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as an active ingredient, which is useful for preventing or treating metabolic disorders, particularly diabetes.

Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium

Compounds that are suitable to be used for three-dimensional optical recording materials, etc. The compounds each have a structure that allows pi-electron conjugation to be achieved by linking a porphyrin ring and a perinaphthothioindigo ring to each other with a straight-chain atomic group. The compounds of the present invention are suitable to be used for three-dimensional optical recording materials, etc. since they have a high two-photon absorption efficiency and undergo photochromism effectively through optical absorption.